President & CEOOfficers of the CorporationBoard of TrusteesFoundation BoardLeadership CouncilAbout Joslin ResearchAdvocacy & Gov't AffairsHistory
Newly DiagnosedManaging DiabetesChildhood DiabetesNutritionExerciseOnline Diabetes ClassesDiscussion BoardsJoslin Clinical ResearchInfo for Healthcare ProfessionalsJoslin Clinical Guidelines
Make an AppointmentAdult ClinicYoung Adult Transition CarePediatricsEye CareWeight Management ProgramsDO ITMental Health & CounselingReferring PhysiciansBillingAfrican American ProgramsAsian ClinicLatino Diabetes InitiativeAbout Joslin ResearchVolunteer for Clinical Research StudiesInfo for Healthcare ProfessionalsClinical Guidelines
Directory of Joslin InvestigatorsDiabetes Research Center Alumni ConnectionVolunteer for Clinical Research Studies
Media RelationsNews ReleasesInside Joslin
Affiliated CentersPharma & DeviceCorporate EducationPublicationsProfessional EducationInternationalCause MarketingHealthcare ProfessionalsCommercialization and VenturesJoslin Institute for Technology Translation (JITT)
Give NowHigh Hopes FundWays to GivePlanned GivingEventsGet InvolvedCorporate & Foundation SupportOur DonorsDevelopment Team

Marcia C. Haigis, Ph.D.

The Haigis lab studies a family of conserved proteins termed sirtuins (SIRT1-7). Sir2 and its homologs extend lifespan in model organisms. We are examining new roles for mammalian sirtuins in the regulation of mitochondrial metabolism. We are also investigating how sirtuins regulate signaling pathways stemming from the mitochondria. First, we have discovered that a mitochondrial sirtuin, SIRT4, regulates fatty acid oxidation. We have also discovered that another mitochondrial sirtuin, SIRT3, is required to achieve maximum metabolic flux in mitochondria. Moreover, we have discovered that SIRT3 loss results in HIF stabilization and increased expression of glycolytic enzymes.

Page last updated: September 21, 2014